Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReDUCE: Diet + Budesonide for UC Flare
NCT05791487Recruiting
- Sponsor
- Edith Wolfson Medical Center
- Start
- Dec 2023
- Primary completion
- Mar 2026
- Countries
- 4
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Edith Wolfson Medical Center. Primary endpoint: Steroid free remission at 12 weeks. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05791487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05791487.